IDH2 and glioma: AG-881(Vorasidenib), a pan-inhibitor of both mutant IDH1 and mutant IDH2, exhibits effective brain penetration accompanied by suppression of 2-HG production in an orthotopic glioma model (IDH1 R132H) [77].